Acute symptomatic seizures in cerebral venous thrombosis
Lindgren, Erik (2021), Acute symptomatic seizures in cerebral venous thrombosis, Dryad, Dataset, https://doi.org/10.5061/dryad.w6m905qm7
To identify characteristics, predictors, and outcomes of acute symptomatic seizures (ASS) in cerebral venous thrombosis (CVT), we investigated 1,281 consecutive adult patients with CVT included from 12 hospitals within the International CVT Consortium.
We defined ASS as any seizure between symptom onset and 7 days after diagnosis of CVT. We stratified ASS into pre-diagnosis and solely post-diagnosis ASS. Status epilepticus (SE) was also analyzed separately. We analyzed predictors for ASS, and association between ASS and clinical outcome (modified Rankin Scale) with multivariable logistic regression.
Of 1,281 eligible patients, 441 (34%) had ASS. Baseline predictors for ASS were intracerebral hemorrhage ([ICH], adjusted odds ratio [aOR] 4.1, 95% confidence interval [CI] 3.0–5.5), cerebral edema/infarction without ICH (aOR 2.8, 95% CI 2.0–4.0), cortical vein thrombosis (aOR 2.1, 95%CI 1.5–2.9), superior sagittal sinus thrombosis (aOR 2.0, 95% CI 1.5–2.6), focal neurologic deficit (aOR 1.9, 95% CI 1.4–2.6), sulcal subarachnoid hemorrhage (aOR 1.6, 95% CI 1.1–2.5) and female-specific risk factors (aOR 1.5, 95% CI 1.1–2.1). Ninety-three (7%) patients had solely post-diagnosis ASS, best predicted by cortical vein thrombosis (positive/negative predictive value 22%/92%). Eighty (6%) patients had SE, independently predicted by ICH, focal neurologic deficits and cerebral edema/infarction. Neither ASS nor SE were independently associated with outcome.
ASS occurred in 1/3 of patients with CVT and was associated with brain parenchymal lesions and thrombosis of the superficial system. In absence of pre-diagnosis ASS, no subgroup was identified with sufficient risk of post-diagnosis ASS to justify prophylactic antiepileptic drug treatment. We found no association between ASS and outcome.